company background image
AMBU B logo

Ambu CPSE:AMBU B Stock Report

Last Price

DKK 106.30

Market Cap

DKK 28.3b

7D

-0.5%

1Y

2.5%

Updated

22 Dec, 2024

Data

Company Financials +

Ambu A/S

CPSE:AMBU B Stock Report

Market Cap: DKK 28.3b

AMBU B Stock Overview

A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details

AMBU B fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 0.08% below our estimate of its fair value

Earnings are forecast to grow 27.03% per year

Earnings grew by 39.9% over the past year

Risk Analysis

Large one-off items impacting financial results


My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
Analyst Price Target
Consensus Narrative from 7 Analysts

Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth

Key Takeaways Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability. Incremental pricing strategies and R&D investments in key segments like GI bolster profitability, operational efficiency, and long-term growth potential in core markets.
View narrative
DKK 127.63
FV
16.7% undervalued intrinsic discount
12.17%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days ago author updated this narrative

Ambu A/S Competitors

Demant

CPSE:DEMANT

DKK 57.3b

Embla Medical hf

CPSE:EMBLA

DKK 14.7b

Coloplast

CPSE:COLO B

DKK 179.5b

Carl Zeiss Meditec

XTRA:AFX

€4.0b

Price History & Performance

Summary of share price highs, lows and changes for Ambu
Historical stock prices
Current Share PriceDKK 106.30
52 Week HighDKK 154.60
52 Week LowDKK 97.86
Beta0.81
1 Month Change-6.71%
3 Month Change-20.40%
1 Year Change2.46%
3 Year Change-37.91%
5 Year Change-5.72%
Change since IPO6,107.30%

Recent News & Updates

Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Nov 28
Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Nov 13
Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Recent updates

Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Nov 28
Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Nov 13
Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Nov 07
Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Sep 02
Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Aug 06
Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Apr 06
Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Mar 14
Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01
Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Jan 02
A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Oct 31
Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 22
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Aug 19
Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Jul 12
Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Jun 22
Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

May 07
Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Mar 24
Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Jan 20
We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

Dec 08
Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Sep 23
Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 08
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Aug 21
We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Jun 06
Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

May 19
These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

Shareholder Returns

AMBU BDK Medical EquipmentDK Market
7D-0.5%-2.9%-13.7%
1Y2.5%0.5%-8.0%

Return vs Industry: AMBU B exceeded the Danish Medical Equipment industry which returned 0.5% over the past year.

Return vs Market: AMBU B exceeded the Danish Market which returned -8% over the past year.

Price Volatility

Is AMBU B's price volatile compared to industry and market?
AMBU B volatility
AMBU B Average Weekly Movement4.8%
Medical Equipment Industry Average Movement3.6%
Market Average Movement4.3%
10% most volatile stocks in DK Market10.6%
10% least volatile stocks in DK Market2.7%

Stable Share Price: AMBU B has not had significant price volatility in the past 3 months compared to the Danish market.

Volatility Over Time: AMBU B's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19375,196Britt Jensenwww.ambu.com

Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Ambu A/S Fundamentals Summary

How do Ambu's earnings and revenue compare to its market cap?
AMBU B fundamental statistics
Market capDKK 28.32b
Earnings (TTM)DKK 235.00m
Revenue (TTM)DKK 5.39b

120.5x

P/E Ratio

5.3x

P/S Ratio

Is AMBU B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMBU B income statement (TTM)
RevenueDKK 5.39b
Cost of RevenueDKK 2.19b
Gross ProfitDKK 3.20b
Other ExpensesDKK 2.97b
EarningsDKK 235.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Jan 30, 2025

Earnings per share (EPS)0.88
Gross Margin59.38%
Net Profit Margin4.36%
Debt/Equity Ratio0%

How did AMBU B perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

43%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:45
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ambu A/S is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael HealyBerenberg
Alexander BerglundBofA Global Research
Lars TopholmCarnegie Investment Bank AB